Trials / Completed
CompletedNCT03848104
Evaluation of the Use of Cefoxitin in Combination in Continuous Parenteral Administration in the Treatment of Bone and Joint Infections
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 35 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- —
Summary
Cephamycin related to 2nd generation cephalosporins, the use of cefoxitin has long been limited to antibiotic prophylaxis. Because of its spectrum (sensitive staphylococci, enterobacteria including ESBL, streptococci, anaerobes), its stability and its low cost, it could be useful in curative bone and joint infections, especially in case of infection polymicrobial disease in patients for whom antibiotic alternative per os is limited.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | bone and joint infection treated with cefoxitin | the patients had cefoxitin in combination in continuous parenteral administration to treat their bone / joint infection |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2018-03-01
- Completion
- 2018-04-01
- First posted
- 2019-02-20
- Last updated
- 2019-02-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03848104. Inclusion in this directory is not an endorsement.